Soluble CD30 in patients with antibody-mediated rejection of the kidney allograft

Transplant Immunology

Volumn 18, Issue 1, 2007, Pages 22-27

  Slavcev, Antonij ^a   Honsova, Eva ^a   Lodererova, Alena ^a   Pavlova, Yelena ^a   Sajdlova, Helena ^a   Vitko, Stefan ^a   Skibova, Jelena ^a   Striz, Ilja ^a   Viklicky, Ondrej ^a  

^a INSTITUTE FOR CLINICAL AND EXPERIMENTAL MEDICINE   (Czech Republic)

Author keywords

Antibody mediated rejection; C4d; Kidney transplantation; Soluble CD30

Indexed keywords

CD30 ANTIGEN; COMPLEMENT COMPONENT C4D;

ACCURACY; ADULT; ANTIBODY RESPONSE; ARTICLE; FEMALE; HUMAN; INCIDENCE; KIDNEY ALLOGRAFT; KIDNEY ALLOGRAFT REJECTION; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY;

ADULT; AGED; ANTIBODIES; ANTIGENS, CD30; COMPLEMENT C4B; FEMALE; GRAFT REJECTION; HUMANS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PEPTIDE FRAGMENTS; TRANSPLANTATION, HOMOLOGOUS;

EID: 34250355053     PISSN: 09663274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trim.2007.04.001     Document Type: Article

References (22)

1. Crespo M., Pascual M., Tolkoff-Rubin N., Mauiyyedi S., Collins A.B., Fitzpatrick D., et al. Acute humoral rejection in renal allograft recipients: i. incidence, serology and clinical characteristics. Transplantation 71 5 (2001) 652-658
2. Moll S., and Pascual M. Humoral rejection of organ allografts. Am J Transplant 5 11 (2005) 2611-2618
3. Colvin R.B., and Smith R.N. Antibody-mediated organ-allograft rejection. Nat Rev Immunol 5 10 (2005) 807-817
4. Feucht H.E. Complement C4d in graft capillaries - the missing link in the recognition of humoral alloreactivity. Am J Transplant 3 6 (2003) 646-652
5. Miller G.G., Destarac L., Zeevi A., Girnita A., McCurry K., Iacono A., et al. Acute humoral rejection of human lung allografts and elevation of C4d in bronchoalveolar lavage fluid. Am J Transplant 4 8 (2004) 1323-1330
6. Honsova E., Lodererova A., Viklicky O., and Boucek P. BK-virus nephropathy and simultaneous C4d positive staining in renal allografts. Cesk Patol 41 4 (2005) 163-166
7. Yard B., Spruyt-Gerritse M., Claas F., Thorogood J., Bruijn J.A., Paape M.E., et al. The clinical significance of allospecific antibodies against endothelial cells detected with an antibody-dependent cellular cytotoxicity assay for vascular rejection and graft loss after renal transplantation. Transplantation 55 6 (1993) 1287-1293
8. Glotz D., Lucchiari N., Pegaz-Fiornet B., and Suberbielle-Boissel C. Endothelial cells as targets of allograft rejection. Transplantation 82 1 Suppl (2006) S19-S21
9. Susal C., Pelzl S., Dohler B., and Opelz G. Identification of highly responsive kidney transplant recipients using pretransplant soluble CD30. J Am Soc Nephrol 13 6 (2002) 1650-1656
10. Pelzl S., Opelz G., Wiesel M., Schnulle P., Schonemann C., Dohler B., et al. Soluble CD30 as a predictor of kidney graft outcome. Transplantation 73 1 (2002) 3-6
11. Susal C., Pelzl S., Simon T., and Opelz G. Advances in pre- and posttransplant immunologic testing in kidney transplantation. Transplant Proc 36 1 (2004) 29-34
12. Matinlauri I.H., Kyllonen L.E., Salmela K.T., Helin H., Pelzl S., and Susal C. Serum sCD30 in monitoring of alloresponse in well HLA-matched cadaveric kidney transplantations. Transplantation 80 12 (2005) 1809-1812
13. Slavcev A., Lacha J., Honsova E., Sajdlova H., Lodererova A., Vitko S., et al. Soluble CD30 and HLA antibodies as potential risk factors for kidney transplant rejection. Transpl Immunol 14 2 (2005) 117-121
14. Rajakariar R., Jivanji N., Varagunam M., Rafiq M., Gupta A., Sheaff M., et al. High pre-transplant soluble CD30 levels are predictive of the grade of rejection. Am J Transplant 5 8 (2005) 1922-1925
15. Vaidya S., Partlow D., Barnes T., Thomas P., and Gugliuzza K. Soluble CD30 concentrations in ESRD patients with and without panel reactive HLA antibodies. Clin Transplant 20 4 (2006) 461-464
16. Vaidya S., Partlow D., Barnes T., and Gugliuzza K. Pretransplant soluble CD30 is a better predictor of posttransplant development of donor-specific antibodies and acute vascular rejection than panel reactive antibodies. Transplantation 82 12 (2006) 1606-1609
17. Weimer R., Susal C., Yildiz S., Staak A., Pelzl S., Renner F., et al. Post-transplant sCD30 and neopterin as predictors of chronic allograft nephropathy: impact of different immunosuppressive regimens. Am J Transplant 6 8 (2006) 1865-1874
18. Racusen L.C., Halloran P.F., and Solez K. Banff 2003 Meeting Report: New Diagnostic Insights and Standards. Am J Transplant 4 10 (2004) 1562-1566
19. Racusen L.C., Colvin R.B., Solez K., Mihatsch M.J., Halloran P.F., Campbell P.M., et al. Antibody-mediated rejection criteria - an addition to the Banff '97 classification of renal allograft rejection. Am J Transplant 3 6 (2003) 708-714
20. Martin S., and Claas F. Antibodies and crossmatching for transplantation. In: Dyer P.A., and Middleton D. (Eds). Histocompatibility testing (1993), Oxford Univ. Press, Oxford 81-105
21. Armitage P., and Berry G. Statistical methods in medical research (1987), Blackwell Scientific Publications, London
22. Mauiyyedi S., and Colvin R.B. Humoral rejection in kidney transplantation: new concepts in diagnosis and treatment. Curr Opin Nephrol Hypertens 11 6 (2002) 609-618